Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Dimpylate
Beaphar B.V.
QP53AF03
Dimpylate
2.1 gram(s)/collar
Medicated collar
CAM: Companion Animal Medicine as defined in relevant national legislation
Cats
dimpylate
Ectoparasiticide
Authorised
2012-06-15
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Beaphar Flea Collar for Cats 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ONE COLLAR OF 35 CM LENGTH (14 G) CONTAINS: ACTIVE SUBSTANCE: Dimpylate (as stabilized diazinon at 92% diazinon) 2.1 g EXCIPIENTS: Erythrosine (E127) 0.042 g For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Collar Red, PVC collar. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cats 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of cats infested with fleas (_Ctenocephalides felis_) 4.3 CONTRAINDICATIONS Do not use in case of hypersensitivity to the active substance, or to any of the excipients. Do not use on sick and recovering cats. Do not use in known cases of liver disorder. Do not use on pregnant animals. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES When fitting, ensure that the collar is not too tight. Loosen the collar as the cat grows bigger. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _2_ _/_ _1_ _1_ _/_ _2_ _0_ _1_ _6_ _C_ _R_ _N_ _ _ _7_ _0_ _2_ _4_ _4_ _4_ _1_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTION(S) FOR USE IN ANIMALS None. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS Due to the potential risk of hypersensitivity developing in humans to dimpylate, unnecessary handling of this product should be avoided. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) An int Прочитать полный документ